Kiniksa Pharmaceuticals

100 Hayden Ave
Lexington,  MA  02421

United States
  • Booth: ES1863


Kiniksa Pharmaceuticals is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from devastating and debilitating diseases with significant unmet medical need. We have built a pipeline of product candidates across various stages of development, currently focused on autoinflammatory and autoimmune diseases. Kiniksa has initiated Rhapsody, a Phase 3 study to assess the efficacy and safety of rilonacept treatment in subjects with recurrent pericarditis. To learn more, visit

 Additional Info

ACC.19 Learning Pathways? (select one)
Interventional Cardiology